Working from home?
Keep your critical coding and billing tools with you no matter where you work.
Create your Find-A-Code account today!
subscribe
5A81.1 Testicular hypofunction International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01 In pre-puberty, a disorder characterised by atrophied testes and sterility, abnormal height and absence of secondary sex characteristics. In post-puberty, a disorder characterised by depressed sexual function, loss of sex drive and sterility, muscle weakness and osteoporosis (due to loss of the androgen anabolic effect).
postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Associated with - multiple selections are allowed [select] 1C41 Bacterial infection of unspecified site – BD75.1 Scrotal varices – LB52 Cryptorchidism –– LB52.0 Ectopic testis –– LB52.1 Undescended testicle, unilateral –– LB52.2 Undescended testicle, bilateral –– LB52.Y Other specified cryptorchidism –– LB52.Z Cryptorchidism, unspecified –– PB20 Unintentional exposure to or harmful effects of opioids or related analgesics –– PB21 Unintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants –– PB22 Unintentional exposure to or harmful effects of psychostimulants –– PB23 Unintentional exposure to or harmful effects of cannabinoids or hallucinogens –– PB24 Unintentional exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs –– PB25 Unintentional exposure to or harmful effects of antidepressants –– PB26 Unintentional exposure to or harmful effects of antipsychotics –– PB27 Unintentional exposure to or harmful effects of antiepileptics or antiparkinsonism drugs –– PB28 Unintentional exposure to or harmful effects of other or unspecified drug, medicament or biological substance –– PB29 Unintentional exposure to or harmful effects of multiple drugs, medicaments or biological substances –– PB30 Unintentional exposure to or harmful effects of alcohols –– PB31 Unintentional exposure to or harmful effects of organic solvents –– PB32 Unintentional exposure to or harmful effects of carbon monoxide –– PB33 Unintentional exposure to or harmful effects of pesticides –– PB34 Unintentional exposure to or harmful effects of corrosive substances –– PB35 Unintentional exposure to or harmful effects of halogen derivatives of aliphatic or aromatic hydrocarbons –– PB36 Unintentional exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source –– PC90 Intentional self-harm by exposure to or harmful effects of opioids or related analgesics –– PC91 Intentional self-harm by exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants –– PC92 Intentional self-harm by exposure to or harmful effects of psychostimulants –– PC93 Intentional self-harm by exposure to or harmful effects of cannabinoids or hallucinogens –– PC94 Intentional self-harm by exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs –– PC95 Intentional self-harm by exposure to or harmful effects of antidepressants –– PC96 Intentional self-harm by exposure to or harmful effects of antipsychotics –– PC97 Intentional self-harm by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs –– PC98 Intentional self-harm by exposure to other and unspecified drug, medicament and biological substance –– PC99 Intentional self-harm by exposure to or harmful effects of multiple drugs, medicaments or biological substances –– PD00 Intentional self-harm by exposure to or harmful effects of alcohols –– PD01 Intentional self-harm by exposure to or harmful effects of organic solvents –– PD02 Intentional self-harm by exposure to or harmful effects of carbon monoxide –– PD03 Intentional self-harm by exposure to or harmful effects of pesticides –– PD04 Intentional self-harm by exposure to or harmful effects of corrosive substances –– PD05 Intentional self-harm by exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source –– PE80 Assault by exposure to or harmful effects of opioids or related analgesics –– PE81 Assault by exposure to or harmful effects of sedative, hypnotic drugs or other CNS depressants –– PE82 Assault by exposure to or harmful effects of psychostimulants –– PE83 Assault by exposure to or harmful effects of cannabinoids or hallucinogens –– PE84 Assault by exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs –– PE85 Assault by exposure to or harmful effects of antidepressants –– PE86 Assault by exposure to or harmful effects of antipsychotics –– PE87 Assault by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs –– PE88 Assault by exposure to or harmful effects of other or unspecified drug, medicament or biological substance –– PE89 Assault by exposure to or harmful effects of multiple drugs, medicaments or biological substances –– PE8Y Other specified assault by exposure to or harmful effects of drugs, medicaments or biological substances –– PE8Z Assault by exposure to or harmful effects of drugs, medicaments or biological substances, unspecified –– PE90 Assault by exposure to or harmful effects of alcohols –– PE91 Assault by exposure to or harmful effects of organic solvents –– PE92 Assault by exposure to or harmful effects of carbon monoxide –– PE93 Assault by exposure to or harmful effects of pesticides –– PE94 Assault by exposure to or harmful effects of corrosive substances –– PE95 Assault by exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source –– PH40 Exposure to or harmful effects of undetermined intent of opioids or related analgesics –– PH41 Exposure to or harmful effects of undetermined intent of sedative hypnotic drugs or other CNS depressants –– PH42 Exposure to or harmful effects of undetermined intent of psychostimulants –– PH43 Exposure to or harmful effects of undetermined intent of cannabinoids or hallucinogens –– PH44 Exposure to or harmful effects of undetermined intent of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs –– PH45 Exposure to or harmful effects of undetermined intent of antidepressants –– PH46 Exposure to or harmful effects of undetermined intent of antipsychotics –– PH47 Exposure to or harmful effects of undetermined intent of antiepileptics or antiparkinsonism drugs ––– PH47.0 Harmful effects of or exposure to mixed antiepileptics, not elsewhere classified, undetermined intent ––– PH47.Z Undetermined intent: Harmful effects of and exposure to noxious substances: Drugs, medicaments or biological substances: Unspecified antiepileptics or antiparkinsonism drugs –– PH48 Exposure to or harmful effects of undetermined intent of other or unspecified drugs, medicaments or biological substances –– PH49 Exposure to or harmful effects of undetermined intent of multiple drugs, medicaments or biological substances –– PH50 Exposure to or harmful effects of undetermined intent of alcohols –– PH51 Exposure to or harmful effects of undetermined intent of organic solvents –– PH52 Exposure to or harmful effects of undetermined intent of carbon monoxide –– PH53 Exposure to or harmful effects of undetermined intent of pesticides –– PH54 Exposure to or harmful effects of undetermined intent of corrosive substances –– PH55 Exposure to or harmful effects of undetermined intent of halogen derivatives of aliphatic or aromatic hydrocarbons –– PH56 Exposure to or harmful effects of undetermined intent of other or unspecified substances chiefly nonmedicinal as to source – PL00 Drugs, medicaments or biological substances associated with injury or harm in therapeutic use – PL01 Complementary or traditional medicines associated with injury or harm in therapeutic use –– PL01.0 Complementary or traditional medicines associated with injury or harm in therapeutic use, Herbal Preparations or Formulas –– PL01.1 Complementary or traditional medicines associated with injury or harm in therapeutic use, Dietary Supplements, Vitamins or Minerals –– PL01.2 Complementary or traditional medicines associated with injury or harm in therapeutic use, Complementary or Traditional Medicines, not elsewhere classified –– PL01.Y Other specified complementary or traditional medicines associated with injury or harm in therapeutic use –– PL01.Z Complementary or traditional medicines associated with injury or harm in therapeutic use, unspecified – PL0Z Substances associated with injury or harm in therapeutic use, unspecified PL13 Mode of injury or harm associated with exposure to a drug, medicament or biological substance – PL13.0 Overdose of substance, as mode of injury or harm – PL13.1 Underdosing, as mode of injury or harm – PL13.2 Drug-related injury or harm in the context of correct administration or dosage, as mode of injury or harm – PL13.3 Incorrect substance, as mode of injury or harm – PL13.5 Incorrect administration of drug or medicament, as mode of injury – PL13.6 Medication or substance that is known to be an allergen, as mode of injury or harm – PL13.7 Medication or substance that is known to be contraindicated for the patient, as mode of injury or harm – PL13.8 Expired or deteriorated medication or substance, as mode of injury or harm – PL13.9 Drug or substance interactions, as mode of injury or harm – PL13.A Inappropriate stoppage or discontinuation of drug, as mode of injury or harm – PL13.Y Other specified mode of injury or harm associated with exposure to a drug, medicament or biological substance – PL13.Z Mode of injury or harm associated with exposure to a drug, medicament or biological substance, unspecified –– PL13.50 Incorrect route of drug or medicament, as mode of injury –– PL13.51 Incorrect rate of drug or medicament, as mode of injury –– PL13.52 Incorrect timing of drug or medicament, as mode of injury –– PL13.53 Incorrect duration of drug or medicament, as mode of injury –– PL13.5Y Other specified incorrect administration of drug or medicament, as mode of injury –– PL13.5Z Incorrect administration of drug or medicament, as mode of injury, unspecified
synonyms Testicular hypofunction hypofunction testicle gonadal insufficiency of testis Testicular hypogonadism NOS undeveloped testis testicular hypogonadism male hypogonadism prepuberal castrate syndrome eunuchoidism deficiency of testicular hormone androgen deficiency 5-alpha-reductase deficiency with male pseudohermaphroditism defect of testicular androgen synthesis 5-alpha-reductase deficiency Male infertility due to a systemic disease Male infertility with normal virilization due to a systemic disease Male infertility with normal virilization due to acquired testicular defects Defective biosynthesis of testosterone in aged men Testicular hypogonadism in aged men defective biosynthesis of testicular androgen Defective biosynthesis of testicular androgen NOS deficiency of testosterone biosynthesis Male infertility associated with autoimmunity Male infertility with normal virilisation due to acquired testicular defect associated with autoimmunity Male infertility associated with drug Male infertility with normal virilisation due to acquired testicular defect associated with drug Drug induced testicular hypofunction Male infertility associated with environmental toxin Male infertility with normal virilisation due to acquired testicular defect associated with environmental toxin Male infertility associated with mycoplasma infection Male infertility associated with radiation Male infertility with normal virilisation due to acquired testicular defect associated with radiation Male infertility associated with spinal cord injury Male infertility with normal virilisation due to testicular defect associated with spinal cord injury Male infertility with normal virilization due to developmental or structural testicular defects Chromosome Y deletion Male sterility due to chromosome Y deletion Partial chromosome Y deletion Male infertility associated with cryptorchidism Male infertility with normal virilisation due to developmental or structural testicular defect associated with cryptorchidism Male infertility associated with varicocele Male infertility with normal virilisation due to a developmental or structural testicular defect associated with varicocele Sertoli cell only syndrome
Thank you for choosing Find-A-Code, please Sign In to remove ads.